On Sunday, May 11, President Donald Trump announced on Truth Social that he would sign an Executive Order today aimed at lowering prescription drug prices. The order refocuses the drug pricing debate, which often is centered around patents, on “equalizing” pricing among developed nations. In his social media post, Trump blamed pharmaceutical companies for chalking up the high price of drugs in the United States to research and development costs. “It was always difficult to explain and very embarrassing because, in fact, there was no correct or rightful answer,” Trump wrote. He also implied that Democrats have resisted efforts to lower prices due to campaign contributions from the industry and said the Order signed today will reduce drug prices “almost immediately, by 30% to 80%” via a “most favored nations” policy that will mandate U.S. citizens pay the same price as the nation paying the lowest price.
Recent Posts
- Mixed UK High Court Ruling Fails to Answer Fundamental Questions of AI Copyright Infringement
- Professors Press SCOTUS to Affirm Copyright Protection for AI-Created Works
- Squires Emphasizes AI, Dubs Inherited Backlog ‘An Absolute Dumpster Fire’ and a ‘Betrayal’
- Federal Circuit Clarifies Precedent on Pre-AIA Prior Art ‘By Another’
- Squires Restores PTAB’s RPI Identification Requirement to Exacting Pre-SharkNinja Standard
